Public Health Issues Related to HPV Vaccination

Hershey, Jody H.; Vélez, Luís Fernando

doi:10.1097/phh.0b013e3181a23de6

Cited by 21 publications

(17 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…11–13 Systematic reviews related to HPV vaccination uptake and completion that have been published in the last decade reflect a wide range of potentially helpful activities, and yet leave many questions unanswered. Brewer 11 noted that differences in healthcare systems and cultural factors may compromise synthesis of studies from different countries, although a number of reviews have included reports of interventions on several continents (e.g., 14,15,16 ).…”

Section: Introductionmentioning

confidence: 99%

Using an Implementation Research Framework to Identify Potential Facilitators and Barriers of an Intervention to Increase HPV Vaccine Uptake

Selove

Foster

Mack

et al. 2017

Journal of Public Health Management and Practice

View full text Add to dashboard Cite

Background Although incidence of cervical cancer has been decreasing in the United States over the last decade, Hispanic and African American women have substantially higher rates compared to Caucasian women. The human papillomavirus (HPV) is a necessary, although insufficient, cause of cervical cancer. In the U.S. in 2013, only 37.6% of girls 13–17 years old received the recommended three doses of a vaccine that is almost 100% efficacious for preventing infection with viruses that are responsible for 70% of cervical cancers. Implementation research has been underutilized in interventions for increasing vaccine uptake. The Consolidated Framework for Implementation Research (CFIR), an approach for designing effective implementation strategies, integrates five domains that may include barriers and facilitators of HPV vaccination. These include the innovative practice (Intervention), communities where youth and parents live (Outer Setting), agencies offering vaccination (Inner Setting), healthcare staff (Providers), and planned execution and evaluation of intervention delivery (Implementation Process). Methods Secondary qualitative analysis of transcripts of interviews with 30 community healthcare providers was conducted using the CFIR to code potential barriers and facilitators of HPV vaccination implementation. Results All CFIR domains except Implementation Process were well-represented in providers’ statements about challenges and supports for HPV vaccination. Conclusion A comprehensive implementation framework for promoting HPV vaccination may increase vaccination rates in ethnically diverse communities. Further research is needed to determine if identifying implementation barriers and facilitators in all five CFIR domains as part of developing an intervention contributes to improved HPV vaccination rates.

show abstract

Section: Introductionmentioning

confidence: 99%

Using an Implementation Research Framework to Identify Potential Facilitators and Barriers of an Intervention to Increase HPV Vaccine Uptake

Selove

Foster

Mack

et al. 2017

Journal of Public Health Management and Practice

View full text Add to dashboard Cite

show abstract

“…Primary prevention through HPV vaccination seems to be a promising tool to prevent cervical cancer (Schiffman and Castle, 2007;Muñoz and Jacquard, 2008;Hershey and Velez, 2009). Many studies indicate that HPV vaccines are safe and that it reduces nearly 70% the probability to develop cervical cancer (Goldie et al, 2008;Hopkins and Wood, 2013).…”

Section: Introductionmentioning

confidence: 99%

Human Papillomavirus Vaccination Acceptability among Female University Students in South Africa

Hoque

Ghuman²,

Hal³

2013

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Background: The objectives of this present study were to assess the awareness of cervical cancer and its risk factors among female undergraduates in South Africa, and to determine the their level of acceptability of Human Papillomavirus (HPV) vaccination. Materials and Methods: This cross-sectional study was conducted in March 2013 among 440 full time undergraduate female students. Results: Of those students who never had sex (n=163), 96 (58.9%) had ever heard of cervical cancer and only 12 students (12.5%) knew that HPV causes cervical cancer. More than a third (35.4%) of the students correctly said that sexual intercourse before age of 18 years is a risk factor for cervical cancer and 55.2% of the students knew about the Pap smear test which is used for screening cervical cancer. The majority (77.3%) were willing to accept HPV vaccination. Results revealed that students who knew about the Pap smear test, and were aware that having multiple sex partners, sexual intercourse before the age of 18 years, smoking and having contracted any STDs are risk factors for cervical cancer were more likely to accept HPV vaccination compared to other groups. Conclusions: The general knowledge of South African female university students about cervical cancer is not sufficient but they have positive attitudes toward getting vaccinated with the HPV vaccine.

show abstract

“…It is estimated that 14 million people acquire new HPV infections annually in the United States [1]. HPV is currently the most common sexually transmitted infection in our country [1][2][3][4], with the highest prevalence in sexually active adolescents and young adults [1][2][3]. There are more than 150 types of HPV, 40 of which infect the genitals [1,5].…”

Section: Introductionmentioning

confidence: 99%